Carol Kearney

Carol Kearney is an accomplished professional with over 25 years of consulting experience that encompasses both prominent industry roles at Pfizer and Pharmacia, as well as the life sciences consulting domain. Her in depth knowledge spans across a diverse array of therapeutic areas, reflecting her deep expertise within the medical and commercial sectors.

Carol possesses a unique ability to seamlessly bridge the gap between commercial and medical organizations when crafting and executing strategies. Notably, Carol has been a trailblazer in the field of ophthalmology, assuming a leadership role that encompasses diseases affecting both the anterior and posterior segments of the eye. This specialized focus has allowed her to carve a niche in the industry, contributing to groundbreaking advancements and informed decision-making within this critical medical field.

Previously serving as a managing director at Clarion, Carol played a crucial role in driving the growth and success of the organization. Additionally, she was a global marketing director at Pfizer, where she oversaw the management of Xalatan®, the world's leading glaucoma medication, as a key member of the global ophthalmology marketing team. Before the merger with Pfizer, Carol worked as a manager in medical marketing for the ophthalmology business at Pharmacia.

More broadly, her areas of expertise include strategy development, implementation, lifecycle management, building and enhancing patient engagement programs, and fostering KOL advocacy. Carol has also gained valuable sales and training experience in both primary care and specialty markets, working across diverse global markets such as Europe, Japan, Latin America, and Asia Pacific.

Carol has a Bachelor of Science in Business Administration from the University of Kansas.